Summary
Policy Topic
Repeal of Hepatitis C Virus (HCV) Checklist – and Elimination of Prior Authorization for Glecaprevir/Pibrentasivir (Mavyret®) and Sofosbuvir/Velpatasvir (Epclusa ®)
Chapter Title
24-06
Short Description
Supplement Numbers 24-06
Policy Topic Repeal of Hepatitis C Virus (HCV) Checklist – and Elimination of Prior Authorization for Glecaprevir/Pibrentasivir (Mavyret®) and Sofosbuvir/Velpatasvir (Epclusa ®) Replaces Supplement 20-13
Date May 14, 2024